Greenwich LifeSciences Statistics
Total Valuation
GLSI has a market cap or net worth of $138.58 million. The enterprise value is $134.48 million.
Important Dates
The last earnings date was Tuesday, April 15, 2025, after market close.
Earnings Date | Apr 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GLSI has 13.27 million shares outstanding. The number of shares has increased by 1.30% in one year.
Current Share Class | 13.27M |
Shares Outstanding | 13.27M |
Shares Change (YoY) | +1.30% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | 54.64% |
Owned by Institutions (%) | 9.62% |
Float | 6.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 54.19 |
P/TBV Ratio | 54.72 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.62
Current Ratio | 2.62 |
Quick Ratio | 2.62 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -341.95% and return on invested capital (ROIC) is -216.74%.
Return on Equity (ROE) | -341.95% |
Return on Assets (ROA) | -180.50% |
Return on Invested Capital (ROIC) | -216.74% |
Return on Capital Employed (ROCE) | -631.87% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.97M |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.81% in the last 52 weeks. The beta is 3.38, so GLSI's price volatility has been higher than the market average.
Beta (5Y) | 3.38 |
52-Week Price Change | -20.81% |
50-Day Moving Average | 10.86 |
200-Day Moving Average | 13.04 |
Relative Strength Index (RSI) | 55.43 |
Average Volume (20 Days) | 161,317 |
Short Selling Information
The latest short interest is 743,316, so 5.60% of the outstanding shares have been sold short.
Short Interest | 743,316 |
Short Previous Month | 658,402 |
Short % of Shares Out | 5.60% |
Short % of Float | 12.34% |
Short Ratio (days to cover) | 21.35 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.01M |
Pretax Income | -9.24M |
Net Income | -15.79M |
EBITDA | -16.01M |
EBIT | -16.01M |
Earnings Per Share (EPS) | -$1.21 |
Full Income Statement Balance Sheet
The company has $4.09 million in cash and n/a in debt, giving a net cash position of $4.09 million or $0.31 per share.
Cash & Cash Equivalents | 4.09M |
Total Debt | n/a |
Net Cash | 4.09M |
Net Cash Per Share | $0.31 |
Equity (Book Value) | 2.53M |
Book Value Per Share | 0.19 |
Working Capital | 2.53M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -7.27M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |